External cardioversion of atrial fibrillation: The role of electrode position on cardioversion success

International Journal of Cardiology

Volumn 137, Issue 1, 2009, Pages

  Vogiatzis, Ioannis A ^a   Sachpekidis, Vasilios ^a   Vogiatzis, Ioannis M ^a   Kambitsi, Efterpi ^a   Karamitsos, Theodoros ^a   Samanidis, Dionisios ^a   Tsagaris, Vasilios ^a   Simeonidou, Olga ^a  

^a GENERAL HOSPITAL OF VERIA   (Greece)

Author keywords

Electrodes position; External cardioversion; Monophasic shock; Persistent atrial fibrillation

Indexed keywords

ACENOCOUMAROL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE MB; DIGOXIN; TROPONIN T;

ADULT; ARTICLE; CARDIOVERSION; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEFIBRILLATOR; ELECTRODE; ENERGY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINUS RHYTHM;

AGED; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; ELECTRODES; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 68949175231     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.05.038     Document Type: Article

References (10)

1. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., and Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 (1998) 946-952
2. Wang T.J., Massaro J.M., Levy D., et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290 (2003) 1049-1056
3. Fuster V., Ryden L.E., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-354
4. Botto G.L., Politi A., Bonini W., Broffoni T., and Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart 82 (1999) 726-730
5. Kirchhof P., Eckardt L., Loh P., et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 360 (2002) 1275-1279
6. Mathew T.P., Moore A., McIntyre M., et al. Randomised comparison of electrode positions for cardioversion of atrial fibrillation. Heart 81 (1999) 576-579
7. Kerber R.E., Grayzel J., Hoyt R., Marcus M., and Kennedy J. Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation 63 (1981) 676-682
8. Kerber R.E. Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances. Am J Cardiol 78 (1996) 22-26 Review
9. Chen C.J., and Guo G.B. External cardioversion in patients with persistent atrial fibrillation: a reappraisal of the effects of electrode pad position and transthoracic impedance on cardioversion success. Jpn Heart J 44 (2003) 921-932
10. Lund M., French J.K., Johnson R.N., Williams B.F., and White H.D. Serum troponins T and I after elective cardioversion. Eur Heart J 21 (2000) 245-253